CK
AGN

Carnick & Kubik’s Allergan Inc AGN Stock Holding History

Carnick & Kubik’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1.32M Buy
+4,918
New +$1.32M 0.39% 58
2015
Q1 		– Sell
-5,666
Closed -$1.21M – 124
2014
Q4 		$1.21M Buy
5,666
+13
+0.2% +$2.58K 1.03% 28
2014
Q3 		$1.01M Buy
+5,653
New +$939K 0.93% 30
2013
Q3 		– Sell
-9,145
Closed -$770K – 118
2013
Q2 		$770K Buy
+9,145
New +$949K 0.95% 44

Other funds holding AGN

SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM
AAC
Asset Advisors Corp Augusta, Georgia $575M AUM 14.42% 1-Year Est. Return

Carnick & Kubik's AGN Position: Q1 2016 in Review

Carnick & Kubik opened a new position in Allergan Inc (AGN) in Q1 2016: 4,918 shares worth $1.32M. The stake represents 0.39% of the portfolio and ranks #58 among its holdings. This is a return to the name: Carnick & Kubik previously reported a position in AGN as recently as Q4 2014.

Carnick & Kubik first reported a position in AGN in Q2 2013 and has held it in 4 quarters since. 23 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Carnick & Kubik held 4,918 shares of Allergan Inc worth $1.32M as of Q1 2016.
  • Allergan Inc was a new Carnick & Kubik position in Q1 2016.
  • Allergan Inc made up 0.39% of Carnick & Kubik's portfolio in Q1 2016, its #58 holding.
  • Carnick & Kubik first reported a position in Allergan Inc in Q2 2013 and has held it in 4 quarters since.
  • 23 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.